Ricinoleic Acid

Ricinoleic Acid

SCHEMBL818822

CCCCCC[C@@H](O)C/C=C\CCCCCCCC(=O)O.N

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 2/20 0.97
▸ FFAR4 Q5NUL3 2/20 0.97
▸ FAAH O00519 3/20 0.74
▸ NFKB1 P19838 1/20 0.72
▸ NFKB2 Q00653 1/20 0.72
▸ RELA Q04206 1/20 0.72
▸ TERT O14746 3/20 0.68
▸ PTPN1 P18031 3/20 0.68
▸ PPARG P37231 3/20 0.68
▸ PPARD Q03181 3/20 0.68
▸ PPARA Q07869 3/20 0.68
▸ MAPT P10636 2/20 0.68
▸ BLM P54132 2/20 0.68
▸ HSD17B10 Q99714 2/20 0.68
▸ FABP4 P15090 2/20 0.68
▸ F7 P08709 2/20 0.68
▸ F3 P13726 2/20 0.68
▸ DUSP3 P51452 2/20 0.68
▸ PTPN7 P35236 2/20 0.68
▸ GMNN O75496 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ricinoleic Acid SCHEMBL28487684 1.00 FFAR1 (0.97) FFAR1FFAR4FAAHNFKB1NFKB2
Ricinoleic Acid SCHEMBL1368723 1.00 FFAR1 (0.97) FFAR1FFAR4FAAHNFKB1NFKB2
Ricinoleic Acid SCHEMBL324045 0.99 FFAR1 (0.94) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL9401994 0.98 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
Ricinoleic Acid SCHEMBL23532631 0.98 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
Ricinoleic Acid SCHEMBL25248998 0.98 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL23925391 0.98 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL22400911 0.98 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL291095 0.98 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2
SCHEMBL15512247 0.98 FFAR1 (1.00) FFAR1FFAR4FAAHNFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119505989-A Cutting fluid for semiconductor material and preparation method thereof 俄美达(武汉)有限公司 2025-02-25 — — CN claimed
CN-111979033-B Diamond wire cutting liquid for sapphire cutting 中科孚迪科技发展有限公司 2022-12-23 — — CN claimed
CN-113171631-B Preparation method of modified-methyl tributyroximo silane extraction separation auxiliary agent 浙江锦华新材料股份有限公司 2022-05-17 — — CN claimed
CN-113171631-A Preparation method of modified-methyl tributyroximo silane extraction separation auxiliary agent 浙江锦华新材料股份有限公司 2021-07-27 — — CN claimed
CN-111909772-A Preparation method of diamond wire cutting fluid for sapphire cutting 中科孚迪科技发展有限公司 2020-11-10 — — CN claimed
US-8440230-B2 Formulation based on micronized natural calcite mineral as a plant booster and mineral fertilizer MIKRO MINERAL USA, INC. (US) 2013-05-14 — — US claimed
EP-2512313-A2 PERSONAL CARE COMPOSITION PROVIDING QUIETNESS AND SOFTNESS ENHANCEMENT AND ARTICLES USING THE SAME Kimberly-Clark Worldwide, Inc. (US) 2012-10-24 — — EP claimed
US-20110269627-A1 FORMULATION BASED ON MICRONIZED NATURAL CALCITE MINERAL AS A PLANT BOOSTER AND MINERAL FERTILIZER MIKRO MINERAL USA, INC. 2011-11-03 — — US claimed
US-20110224080-A1 FORMULATION BASED ON MICRONIZED NATURAL CALCITE MINERAL AND MICRONIZED ZEOLITE AS AN ENHANCED PLANT BOOSTER AND MINERAL FERTILIZER MIKRO MINERAL USA, INC. 2011-09-15 — — US claimed
EP-2361332-A2 PERSONAL CARE COMPOSITION PROVIDING QUIETNESS AND SOFTNESS ENHANCEMENT, METHODS OF PREPARING AND ARTICLES USING THE SAME Kimberly-Clark Worldwide, Inc. (US) 2011-08-31 — — EP claimed
WO-2011073816-A2 PERSONAL CARE COMPOSITION PROVIDING QUIETNESS AND SOFTNESS ENHANCEMENT AND ARTICLES USING THE SAME KIMBERLY-CLARK WORLDWIDE, INC. (US) 2011-06-23 — — WO claimed
WO-2010073144-A2 PERSONAL CARE COMPOSITION PROVIDING QUIETNESS AND SOFTNESS ENHANCEMENT, METHODS OF PREPARING AND ARTICLES USING THE SAME KIMBERLY-CLARK WORLDWIDE, INC. (US) 2010-07-01 — — WO claimed
US-20100158964-A1 Personal Care Composition Providing Quietness and Softness Enhancement and Articles Using the Same KIMBERLY-CLARK WORLDWIDE, INC. 2010-06-24 — — US claimed
US-20100158986-A1 Personal Care Composition Providing Quietness and Softness Enhancement, Methods of Preparing and Articles Using the Same KIMBERLY-CLARK WORLDWIDE, INC. 2010-06-24 — — US claimed
WO-2010001184-A1 FORMULATION BASED ON MICRONIZED NATURAL CALCITE MINERAL AND MICRONIZED ZEOLITE AS AN ENHANCED PLANT BOOSTER AND MINERAL FERTILIZER NOVATECH D.O.O. (HR) 2010-01-07 — — WO claimed
WO-2009087426-A1 FORMULATION BASED ON MICRONI ZED NATURAL CALCITE MINERAL AS A PLANT BOOSTER AND MINERAL FERTILIZER NOVATECH D.O.O. (HR) 2009-07-16 — — WO claimed
US-12509820-B2 Methods of providing treated fabrics and light-blocking elements EASTMAN KODAK COMPANY (US) 2025-12-30 — — US disclosed
US-12502865-B2 Patterned light-blocking elements EASTMAN KODAK COMPANY (US) 2025-12-23 — — US disclosed
US-3948822-A DISODIUM-N-OCTADECYL SULFOSUCCINAMATE, SODIUM FORMALDEHYDE SULFOXYLATE CHEMISCHE INDUSTRIE AKU-GOODRICH B.V. (NL) 1976-04-06 — — US disclosed
US-3947394-A 2,6-BIS(2,4-DIHYDROXY PHENYLMETHYL)-4-CHLOROPHENOL THE GENERAL TIRE & RUBBER COMPANY (US) 1976-03-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224080-A1 FORMULATION BASED ON MICRONIZED NATURAL CALCITE MINERAL AND MICRONIZED ZEOLITE AS AN ENHANCED PLANT BOOSTER AND MINERAL FERTILIZER MAX, CAMK2G, SLC39A3 FFAR1 4574/4885FFAR4 3993/4885FAAH 4823/4885
US-12509820-B2 Methods of providing treated fabrics and light-blocking elements CRYAB, HBB, CFB FFAR1 571/4885FFAR4 277/4885FAAH 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback